CLINICAL TRIALS PROFILE FOR CARDIOGEN-82
✉ Email this page to a colleague
All Clinical Trials for CARDIOGEN-82
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01424774 ↗ | Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning | Completed | Bracco Diagnostics, Inc | 2011-09-01 | This study will be performed at clinical sites that have administered CardioGen-82® to patients from January to July 2011. The patients enrolled(i.e., "target date patients") will be all those who were dosed at the end of use of the CardioGen-82® generators on the last day of generator use from the generator that was used immediately prior to the recalled generator (i.e., "target date generators"). These are not patients who received drug eluted from the recalled generator. Of these patients, it is planned that 100 patients will be entered in this trial. | |
| NCT01430975 ↗ | Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning at Two Clinical Sites | Completed | Bracco Diagnostics, Inc | 2011-09-01 | This study is to be performed at two clinical sites where patients received CardioGen-82 during the time period January to June, 2011 and where patients were scanned chronologically near to the index patients (2 days before or after). Of these, it is planned that at least 30 patients will be entered in this trial. Index patient is the term applied to individuals who had radiation spectra indicative of Sr-82 and Sr-85 detected by hand-held survey meters. | |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CARDIOGEN-82
Condition Name
Clinical Trial Locations for CARDIOGEN-82
Trials by Country
Clinical Trial Progress for CARDIOGEN-82
Clinical Trial Phase
Clinical Trial Sponsors for CARDIOGEN-82
Sponsor Name
